Page 31 - Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) and NextCure (NASDAQ:NXTC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Earnings & Valuation This table compares NGM Biopharmaceuticals […]

Data from several recent phase 3 trials support changes to standard care for NSCLC, according to researchers. Data from several recent phase 3 trials support changes to standard care for NSCLC, according to researchers.

This information is not intended for residents of the United Kingdom, United States, Australia, Canada or Japan. See Annex for full disclaimer. TME PHARMA...

/PRNewswire/ -- SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the...

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing agreement with Hilleman Laboratories, a vaccines and biologics...